Add BrightSurf on Google Email

New chemical tool for infection research: Visualizing the sphingomyelin metabolism

Scientists have created a new chemical probe to visualize the distribution of sphingomyelin and its degradation by sphingomyelinase during infections. The researchers observed increased metabolization of sphingomyelin molecules during Chlamydia infection, paving the way for targeted strategies against infectious diseases.

SourceUniversity of Würzburg·JournalNature Communications·TypeExperimental study·DateAug 29, 2024

Penn pioneers a 'one-pot platform' to promptly produce mRNA delivery particles

The University of Pennsylvania team has pioneered a novel 'one-pot platform' to produce mRNA delivery particles, accelerating the synthesis process and enabling precise targeting of specific organs. The approach leverages click-like chemistry to create lipid nanoparticles with biodegradable components, enhancing mRNA delivery into cells.

SourceUniversity of Pennsylvania·JournalNature Chemistry·TypeExperimental study·DateJul 9, 2024

Potential new treatment option for diabetic retinopathy

Researchers have developed a new treatment for diabetic retinopathy that addresses the root cause of the disease, preventing progression and potential blindness. The anti-ceramide immunotherapy has been shown to be effective in animal and cell culture models, offering a safer alternative to current treatments.

SourceUniversity of Oklahoma·JournalCell Metabolism·TypeExperimental study·DateJun 17, 2024

The body’s own lipids affect mental disorders: Can specific inhibitors help?

Research suggests that altered lipid signaling in brain cells contributes to mental disorders, with specific inhibitors showing promise in rebalancing this mechanism. The study found similar changes in both human patients and healthy relatives, as well as mice with genetic disorders, opening up new treatment opportunities.

SourceUniversity of Cologne·JournalMolecular Psychiatry·TypeExperimental study·DateJun 6, 2024

RNA inhibitor is shown safe and effective in reducing a wide range of cholesterol and triglyceride levels in the blood in Mount Sinai-led clinical trial

A clinical trial led by Mount Sinai researchers shows zodasiran, an RNA inhibitor targeting ANGPTL3, significantly reduces various types of cholesterol and triglycerides. The therapy also lowers apolipoprotein B, a lipid-transporting protein linked to heart disease.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMay 29, 2024

New resource pinpoints inner workings of sorghum plant cells

A new resource has been created to provide a deeper understanding of the bioenergy crop sorghum and its potential for genetic modification. The study identified gene expression patterns in sorghum stem cells, which can help researchers design cell-type specific promoters for targeted gene expression.

An omega-6 fatty acid may reduce the risk for bipolar disorder

Researchers found a genetic link between higher circulating levels of arachidonic acid and lower risk for bipolar disorder. The study suggests that altering arachidonic acid synthesis pathways may reduce bipolar disorder risk, particularly in those with compromised pathways.

SourceElsevier·JournalBiological Psychiatry·TypeComputational simulation/modeling·DateApr 30, 2024

Unveiling the molecular functions of lipid droplet proteins in Arabidopsis thaliana leaves

A study published in Frontiers in Plant Science reveals that leaf lipid droplets contain myosin-binding proteins and enzymes associated with furan-containing fatty acid biosynthesis. This discovery paves the way for future research into leaf lipid droplet functions, potentially leading to advancements in lipid production technology.

SourceChiba University·JournalFrontiers in Plant Science·TypeExperimental study·DateApr 23, 2024

Lipids with potential health benefits in herbal teas

Researchers at Hokkaido University identified 341 different molecular species of lipids in four types of herbal tea, which may contribute to the teas' health benefits. The study reveals significant variations in lipids among the teas, with some containing novel short-chain fatty acid esters and polyunsaturated fatty acids.

SourceHokkaido University·JournalFood Chemistry·TypeExperimental study·DateMar 29, 2024

Lighting the way to noninvasive blood glucose monitoring using portable devices

A novel approach estimates metabolic activity and infers blood glucose levels from near-infrared measurements in commercial smartphones and smartwatches. The phase delay between oxyhemoglobin and deoxyhemoglobin signals closely relates to oxygen consumption during cardiac cycles, serving as a gauge for metabolism.

SourceSPIE--International Society for Optics and Photonics·JournalJournal of Biomedical Optics·DateMar 8, 2024

Precision pulmonary medicine: Penn engineers target lung disease with lipid nanoparticles

Researchers at the University of Pennsylvania have developed a new method to efficiently determine which lipid nanoparticles are likely to bind to the lungs, rather than the liver. This breakthrough enables targeted delivery of mRNA therapeutics beyond the liver, offering new hope for treatments of cystic fibrosis and lung cancer.

SourceUniversity of Pennsylvania School of Engineering and Applied Science·JournalNature Communications·TypeExperimental study·DateMar 1, 2024

A moonshot for obesity: New molecules, inspired by space shuttles, advance lipid nanoparticle delivery for weight control

Researchers at the University of Pennsylvania School of Engineering and Applied Science have invented a new way to synthesize key components of lipid nanoparticles, simplifying their manufacture while boosting efficacy. The new method involves combining three chemicals to create branched lipidoids that promote mRNA delivery to target c...

SourceUniversity of Pennsylvania School of Engineering and Applied Science·JournalNature Communications·TypeExperimental study·DateFeb 26, 2024

Access to prescribed PCSK9 inhibitors remains a significant barrier leaving patients at risk for heart attacks and strokes

A new study reveals that utilization of PCSK9 inhibitors is low among high-risk patients, despite extensive evidence documenting their role in LDL-C reduction and the prevention of heart attacks. The study found that insurance coverage rejection or abandonment leads to significantly more cardiovascular events within 12 months.

SourceFamily Heart Foundation·JournalCirculation Cardiovascular Quality and Outcomes·TypeData/statistical analysis·DateFeb 20, 2024

Scientists develop color-changing dyes that light up cellular activity and enable “time travel” within cells

Researchers have created fluorescent, colour-changing dyes that can visualise multiple distinct biological environments using only one dye. These dyes enable 'time travel' within cells by allowing scientists to distinguish between cellular and delivery vessel environments in real-time. The breakthrough has significant implications for ...

SourceTrinity College Dublin·JournalChem·DateFeb 15, 2024

New study unveils machine learning-aided non-invasive imaging for rapid liver fat visualization

A new study introduces a machine learning-aided non-invasive imaging technique that can rapidly visualize liver fat distribution, enabling early diagnosis and treatment of liver diseases. The method uses near-infrared hyperspectral imaging and machine learning to differentiate between types of lipids in the liver.

SourceTokyo University of Science·JournalScientific Reports·TypeExperimental study·DateJan 9, 2024

University of Toronto researchers discover new lipid nanoparticle that shows muscle-specific mRNA delivery, reduces off-target effects.

Researchers at the University of Toronto have discovered a novel ionizable lipid nanoparticle that enables efficient muscle-focused mRNA delivery while minimizing off-target effects. The study demonstrates potent cellular immune responses and potential as a viable candidate for cancer vaccine development.

SourceUniversity of Toronto - Leslie Dan Faculty of Pharmacy·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateDec 8, 2023